. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Aminobutyrates/adverse effectsAminobutyrates/pharmacologyAminobutyrates/therapeutic useAngiotensin II Type 1 Receptor Blockers/adverse effectsAngiotensin II Type 1 Receptor Blockers/pharmacologyAngiotensin II Type 1 Receptor Blockers/therapeutic useAntihypertensive Agents/administration & dosageAntihypertensive Agents/pharmacologyAntihypertensive Agents/therapeutic useBlood Pressure/drug effectsClinical Trials, Phase II as TopicDrug CombinationsHumansHypertension/drug therapyHypertension/physiopathologyNeprilysin/antagonists & inhibitorsTetrazoles/adverse effectsTetrazoles/pharmacologyTetrazoles/therapeutic use
Substances: See more » AminobutyratesAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsDrug CombinationsTetrazolesNeprilysinsacubitril and valsartan sodium hydrate drug combination
Year: 2010 PMID: 20431556 DOI: 10.1038/nrd3172
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694